Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Linkster Therapeutics
Zurich, Zurich, Switzerlandlinkstertx.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Linkster Therapeutics has developed proprietary platforms for high-throughput antibody discovery and engineering. The company focuses on creating next-generation targeted therapeutics with improved tissue specificity. As of now, there are no programs in clinical trials according to ClinicalTrials.gov. They have established revenue-generating partnerships with global pharma/biotech companies to advance drug candidates toward development milestones.
- Therapeutic areas
- Rare Diseases
- Modalities
- Multi-specific antibodiesAntibody-drug conjugates (including small molecules, RNA, DNA conjugates)Sybodies (synthetic nanobodies)
- Industry
- Biotech
02
Partnerships
Several agreements with pharmaceutical and biotech companies for co-development and advancement of innovative therapeutic products.
Beyond the preview
Go deeper on Linkster Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Linkster Therapeutics.